首页 > 新书资源
新书资源(2007年11月)

Neurobiology of Alzheimers disease / [edited by] David Dawbarn and Shelley J. Allen. — 2nd ed.— New York ; Oxford : Oxford University Press, 2001.—(64.1984/N494n/2nd ed.)

Contents

    Contents
    
    Colour plate section between pp. 176 and 177
    List of contributors ix
    List of abbreviations xiii
    1 Mzheimer's disease: past, present, and future themes 1
     Shelley J. Allen
    2 The neuropathology of Mzheimer's disease 33
     Margaret M. Esiri3 Molecular genetics of Alzheimer's disease 54
     Wilma Wasco
    4 The biology and molecular neuropathology of β-amyloid protein 75
     D. R. Howlett, D. Allsop, and E. H. Karran
    5 The molecular basis of tau protein pathology in
     Mzheimer's disease and related neurodegenerative dementias 103
     Claude M. Wischik, Franz Theuring, and Charles R. Harrington
    6 Apolipoprotein E as a risk factor for Alzheimer's disease 207
     Ann M. Saunders
    7 The Presenilins 227
     Martin Citron
    8 Transgenic models of Mzheimer's disease neuropathology 241
     Karen Duff
    9 Cellular targets of amyloid beta peptide: potential roles in neuronal cell
     stress and toxicity 252
     Shi Du Yan, Alex Roher, Claudio Soto, Futwan Al-Mohanna, Kate ColIison,<br>     Ann Marie Schmidt and David Stern
    10 Reflections on Alzheimer's disease as a specific neurotransmitter
     disorder 270
    Peter Davies
    11 Clinical assessment of Mzheimer's disease 280
     Suzanne Jeffries and Alistair Burns
    12 Molecular and biological markers for diagnosing and monitoring
     the progression of Alzheimer's disease 294
     Hiroyuki Arai, Makoto Higuchi, Noboyuki Okamura, Yu-ichi Morikawa,<br>     Susumu Higuchi, Takeshi Iwatsubo, Eugeen Vanmechelen, Hugo Vanderstichele,<br>     John Q. Trojanowski, and Hidetada Sasaki
    13 Alzheimer's disease and neuroimaging 312
     Nick Fox, Rachael Scahill, Peter Hogh, and Martin Rossor
    14 Current pharmacological approaches to treating Alzheimer's disease 338
     Rebecca Eastley, Gordon Wilco&, and David Dawbarn
    15 Current perspectives, future directions 369
     Stephen L Gracon and Mark Emmerling
    Appendices 389
    AI Amyloid precursor protein 389
    AII Presenilin 1 392
    AIII Presenilin 2 394
    AIV Apolipoprotein E 396
    AV Tau 398
    AVI α,β and γ-secretases 400
    Index 405